Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Pitt

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Archives of Neurology|July 14, 2010
Imaging cortical lesions in multiple sclerosis with ultra-high-field magnetic resonance imagingDavid Pitt, Aaron Boster, Wei Pei, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|June 6, 2022
Susceptibility source separation from gradient echo data using magnitude decay modelingAlexey V Dimov, Thanh D Nguyen, Kelly M Gillen, et al.
Acta Neuropathologica Communications|August 14, 2019
The landscape of myeloid and astrocyte phenotypes in acute multiple sclerosis lesionsCalvin Park, Gerald Ponath, Maya Levine-Ritterman, et al.
International Journal of Molecular Sciences|March 13, 2024
Siponimod Attenuates Neuronal Cell Death Triggered by Neuroinflammation via NFκB and Mitochondrial PathwaysMikel Gurrea-Rubio, Qin Wang, Elizabeth A Mills, et al.
JCI Insight|September 8, 2017
Podoplanin is a negative regulator of Th17 inflammationAlyssa N Nylander, Gerald D Ponath, Pierre-Paul Axisa, et al.
JAMA Neurology|January 23, 2013
Lessons learned from fatal progressive multifocal leukoencephalopathy in a patient with multiple sclerosis treated with natalizumabAaron L Boster, Jacqueline A Nicholas, Ilir Topalli, et al.
Stem Cells Translational Medicine|January 17, 2015
Concise review: modeling multiple sclerosis with stem cell biological platforms: toward functional validation of cellular and molecular phenotypes in inflammation-induced neurodegenerationJoshua C Orack, Michela Deleidi, David Pitt, et al.
Neurology|March 18, 2016
CNS demyelination and enhanced myelin-reactive responses after ipilimumab treatmentYonghao Cao, Alyssa Nylander, Sriram Ramanan, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 10, 2020
Differential expression of the T-cell inhibitor TIGIT in glioblastoma and MSLiliana E Lucca, Benjamin A Lerner, Calvin Park, et al.
Brain Communications|February 7, 2025
Quantitative susceptibility mapping is more sensitive and specific than phase imaging in detecting chronic active multiple sclerosis lesion rims: pathological validationKelly M Gillen, Thanh D Nguyen, Alexey Dimov, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Archives of Neurology|July 14, 2010
Imaging cortical lesions in multiple sclerosis with ultra-high-field magnetic resonance imagingDavid Pitt, Aaron Boster, Wei Pei, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|June 6, 2022
Susceptibility source separation from gradient echo data using magnitude decay modelingAlexey V Dimov, Thanh D Nguyen, Kelly M Gillen, et al.
Acta Neuropathologica Communications|August 14, 2019
The landscape of myeloid and astrocyte phenotypes in acute multiple sclerosis lesionsCalvin Park, Gerald Ponath, Maya Levine-Ritterman, et al.
International Journal of Molecular Sciences|March 13, 2024
Siponimod Attenuates Neuronal Cell Death Triggered by Neuroinflammation via NFκB and Mitochondrial PathwaysMikel Gurrea-Rubio, Qin Wang, Elizabeth A Mills, et al.
JCI Insight|September 8, 2017
Podoplanin is a negative regulator of Th17 inflammationAlyssa N Nylander, Gerald D Ponath, Pierre-Paul Axisa, et al.
JAMA Neurology|January 23, 2013
Lessons learned from fatal progressive multifocal leukoencephalopathy in a patient with multiple sclerosis treated with natalizumabAaron L Boster, Jacqueline A Nicholas, Ilir Topalli, et al.
Stem Cells Translational Medicine|January 17, 2015
Concise review: modeling multiple sclerosis with stem cell biological platforms: toward functional validation of cellular and molecular phenotypes in inflammation-induced neurodegenerationJoshua C Orack, Michela Deleidi, David Pitt, et al.
Neurology|March 18, 2016
CNS demyelination and enhanced myelin-reactive responses after ipilimumab treatmentYonghao Cao, Alyssa Nylander, Sriram Ramanan, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 10, 2020
Differential expression of the T-cell inhibitor TIGIT in glioblastoma and MSLiliana E Lucca, Benjamin A Lerner, Calvin Park, et al.
Brain Communications|February 7, 2025
Quantitative susceptibility mapping is more sensitive and specific than phase imaging in detecting chronic active multiple sclerosis lesion rims: pathological validationKelly M Gillen, Thanh D Nguyen, Alexey Dimov, et al.
Pageof 6